Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma

Glioblastoma multiforme (GBM) is a lethal disease characterized by an overall survival of about 1 year, making it one of the most aggressive tumours, with very limited therapeutic possibilities. Specific biomarkers for early diagnosis as well as innovative therapeutic strategies are urgently needed...

Full description

Bibliographic Details
Main Authors: Beatrice Dufrusine, Emily Capone, Sara Ponziani, Rossano Lattanzio, Paola Lanuti, Francesco Giansanti, Vincenzo De Laurenzi, Stefano Iacobelli, Rodolfo Ippoliti, Annunziato Mangiola, Gianluca Trevisi, Gianluca Sala
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Molecular Oncology
Subjects:
antibody–drug conjugates
extracellular vesicles
glioblastoma
LGALS3BP
liquid biopsy
Online Access:https://doi.org/10.1002/1878-0261.13453

Internet

https://doi.org/10.1002/1878-0261.13453

Similar Items